ArticleJDR clinical and translational research2026
Perspectives of Dental Stakeholders on the Clinical Use of Silver Diamine Fluoride in Australia for Caries.
Article in JDR clinical and translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSilver diamine fluoride (SDF) is an effective cariostatic agent that has reemerged globally in recent years. Its resurgence is timely as dental caries remains prevalent, necessitating an affordable and simple treatment option. Its implementation in Australia has been slow, with inconsistent views on its use among practitioners, but is likely imminent given the recent global uptake. There is currently no literature examining Australian dental stakeholder views on SDF's implementation.
objectivesThis study aims to investigate Australian dental stakeholder views on the use of SDF and to identify the challenges and facilitators to its implementation for managing dental caries.
methodsQualitative semi-structured interviews were conducted with Australian dental stakeholders. The analysis was carried out using Braun and Clarke's reflexive thematic analysis framework and NVivo14 software.
resultsTen participants were interviewed (7 dentists, 2 hygiene therapists, and 1 hygienist) from 4 Australian states. The barriers and facilitators to Australia's use of SDF were found within the themes of policy, research, manufacturer, teaching and exposure, and clinical setting. Major barriers to SDF adoption include insufficient training in the undergraduate setting, lack of a standardized Australian guideline detailing use, no Therapeutic Goods Administration approval for caries, and the manufacturer's product design. Facilitators included continual professional development on SDF, manufacturer marketing of the product, and ample research supporting SDF's effectiveness for dental caries.
conclusionsThis study highlights both barriers and facilitators to SDF use in Australia, providing insight into factors that may influence its future integration into dental practice.Knowledge Transfer Statement:The results of this study show that successful implementation into Australia will require effort and changes by policymakers, universities, and manufacturers to support clinician use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.